Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A systematic umbrella review of 72 meta-analyses synthesizing evidence from 7,367 articles on 101 risk factors for metabolic syndrome, providing comprehensive pooled estimates with confidence intervals and heterogeneity assessment.
Single-centre mechanistic study combining human transcriptomics reanalysis with mouse disease modelling and in vitro fibroblast manipulation; identifies a putative fibroblast state and pathway associations but lacks clinical endpoints and acknowledges need for further work to establish causality and clinical relevance.
First-in-kind proof-of-concept study in animal models demonstrating a novel engineered bacterial platform; lacks human efficacy data, comparator arm, and dose-ranging or safety characterization needed to establish clinical relevance.
This is a narrative review summarizing design strategies and emerging biomaterial approaches for osteomyelitis; it raises questions about clinical translation rather than reporting new evidence or trials.